How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Nate Baxter says the company has about 40 AI use cases as it looks to boost productivity and modernize its business. Cerebras Systems co-founder and CEO Andrew Feldman discusses the company’s Q2 ...

OpenAI’s Computer History turns Mac activity into searchable memories. See how it works, who can use it, and the privacy and security risks. If you can only read one tech story a day, this is it. We ...

News headlines Recursion Pharmaceuticals has made significant strides in its AI-driven drug discovery platform, reporting promising clinical milestones. However, recent earnings revealed a 46.77% ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...